PMC6334651_01
A. MRI liver, demonstrating an enhancing lesion (arrow). B. PET CT image with enhancing lesions in the liver (arrow), spleen, and cervical spine (arrow). C. H&E stained section of the tumor (400x) D. Positive staining with antibody to smooth muscle actin (400x) E. Positive in-situ hybridization for EBV (400x) F. PET, 2 years post-transplant with resolution of enhancement.
nihms-999990-f0001.jpg
PMC6334651_01_nihms-999990-f0001.jpg
F1
Radiology, including MR of the liver and PET-CT scans of the torso, has demonstrated stability or involution of solid lesions and loss of PET enhancement in the liver, spleen and spinal lesions. (Figure 1).